Evidence map›Paper›PMID 33956252›Full record

ArticleJournal of bioenergetics and biomembranes2021

Glutaredoxin 1 protects neurons from oxygen-glucose deprivation/reoxygenation (OGD/R)-induced apoptosis and oxidative stress via the modulation of GSK-3β/Nrf2 signaling.

Zhengguo Qiu, Xu Li, Chongzhen Duan, Rui Li, Lifeng Han

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zhengguo QiuDepartment of Anesthesiology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, No. 2 Weiyang West Road, Xianyang, Shaanxi Province, 712000, China.ORCID 0000-0003-0013-911X
Xu LiDepartment of Surgery and Anesthesiology, Xi'an Hospital of Traditional Chinese Medicine, No. 69 Fengcheng Eight Road, Xi'an, Shaanxi Province, 710200, China.
Chongzhen DuanDepartment of Anesthesiology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, No. 2 Weiyang West Road, Xianyang, Shaanxi Province, 712000, China.
Rui LiDepartment of Anesthesiology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, No. 2 Weiyang West Road, Xianyang, Shaanxi Province, 712000, China.
Lifeng HanDepartment of Anesthesiology, The First Hospital of Yulin, No. 93 Yuxi Street, Yulin, Shaanxi, 719000, China. misslifeng_han@163.com.ORCID 0000-0002-7319-7313
Affiliated Hospital of Shaanxi University of Chinese Medicine · CNShaanxi Provincial Hospital of Traditional Chinese Medicine · CNYulin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence has indicated that glutaredoxin 1 (GRX1) is a potent antioxidant protein that promotes cell survival under conditions of oxidative stress. Oxidative stress-induced neuronal injury contributes to cerebral ischemia/reperfusion injury. However, the role of GRX1-mediated antioxidant defense against neuronal damage during cerebral ischemia/reperfusion injury has not been thoroughly investigated. Thus, the objective of this study was to evaluate whether GRX1 protects neurons against oxygen-glucose deprivation/reoxygenation (OGD/R)-evoked oxidative stress injury in an in vitro model of cerebral ischemia/reperfusion injury. Our data revealed that GRX1 was induced by OGD/R treatment in neurons. Functional assays indicated that loss of GRX1 exacerbated OGD/R-induced apoptosis and the generation of reactive oxygen species (ROS), while GRX1 up-regulation protected against OGD/R-evoked neuronal injury. Further investigation revealed that GRX1 promoted the nuclear expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and enhanced transcription of the Nrf2/antioxidant response element (ARE) in GOD/R-exposed neurons. Furthermore, GRX1 promoted the activation of Nrf2/ARE associated with the modulation of glycogen synthase kinase-3β (GSK-3β). GSK-3β inhibition blocked GRX1 knockdown-mediated suppression of Nrf2 activation. Notably, the suppression of Nrf2 partially reversed GRX1-mediated anti-oxidative stress injury in OGD/R-exposed neurons. In summary, these findings indicate that GRX1 protects neurons against OGD/R-induced oxidative stress injury by enhancing Nrf2 activation via the modulation of GSK-3β. Our study suggests that GRX1 is a potential neuroprotective protein that protects against cerebral ischemia/reperfusion injury.

Indexed as

AnimalsApoptosisGlutaredoxinsGlycogen Synthase Kinase 3 betaMiceNeuronsNF-E2-Related Factor 2Oxidative StressOxygenReactive Oxygen SpeciesGlrx protein, mouseGlutaredoxinsGlycogen Synthase Kinase 3 betaNfe2l2 protein, mouseNF-E2-Related Factor 2OxygenReactive Oxygen SpeciesGRX1GSK-3βNrf2.Oxidative stressOxygen‐glucose deprivation/reoxygenation

Identifiers

PMID33956252
OpenAlexW3159324007

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.